Relyea Zuckerberg Hanson LLC Abbott Laboratories Transaction History
Relyea Zuckerberg Hanson LLC
- $741 Million
- Q4 2024
A detailed history of Relyea Zuckerberg Hanson LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Relyea Zuckerberg Hanson LLC holds 23,609 shares of ABT stock, worth $3.09 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
23,609
Previous 8,649
172.97%
Holding current value
$3.09 Million
Previous $986,000
170.79%
% of portfolio
0.36%
Previous 0.15%
Shares
23 transactions
Others Institutions Holding ABT
# of Institutions
3,377Shares Held
1.33BCall Options Held
10.6MPut Options Held
8.72M-
Vanguard Group Inc Valley Forge, PA169MShares$22.1 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.2 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.1 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.89 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.08 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $229B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...